PROductivity Study of Presbyopia Elimination in Rural-dwellers III
PROSPERIII
Effects of Near Vision Spectacle Correction on Work Retention Among Textile Factories Workers in India
1 other identifier
interventional
1,291
1 country
1
Brief Summary
The investigators will conduct an embedded mixed methods study in which the primary approach is a randomized controlled trial (RCT), and the secondary or embedded approach is a descriptive qualitative study. The aim of the RCT is to assess the impact of presbyopic correction on workplace productivity and retention in the textile industry in a low middle-income country. Additional qualitative data will be collected to enhance understanding of factors linked to reasons why enrolled sew-ers left their job during the study. Participants will be textile workers aged 30 years and above with uncorrected presbyopia who are employed by Shahi Exports Private Limited in Karnataka, India.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 21, 2020
CompletedFirst Posted
Study publicly available on registry
December 4, 2020
CompletedStudy Start
First participant enrolled
May 21, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 5, 2025
CompletedApril 29, 2024
April 1, 2024
10 months
October 21, 2020
April 25, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Work retention
Proportion of textile workers who continue to work at the textile factories assessed from trial entry to closure as recorded in Shahi's Human Resource Management Database
September 2022 to May 2024; Over the 18 month follow-up period from enrolment to study completion
Secondary Outcomes (14)
Compliance with spectacle wear
3, 6, 9, 12, 15 and 18 months after enrolment
Change in work satisfaction
Between baseline and 3, 6, 9, 12, 15 and 18 months after enrolment
Change in feeling valued-at-work
Between baseline and 3, 6, 9, 12, 15 and 18 months after enrolment
Change in likeliness to stay at work
Between baseline and 3, 6, 9, 12, 15 and 18 months after enrolment
Change in work efficiency
Between baseline and 3, 6, 9, 12, 15 and 18 months after enrolment
- +9 more secondary outcomes
Study Arms (2)
Intervention
EXPERIMENTALWorkers assigned to the intervention group will receive free spectacles of a design they select, based on the worker's measured refractive power and dispensed one week later at the factory by the study ophthalmic personnel.
Control
NO INTERVENTIONWorkers assigned to the Control group will receive similar free glasses at the end of the study assessment (18 months).
Interventions
Intervention group workers receive free glasses within one week of undergoing vision assessment (May 2022). The duration of the treatment for the Intervention participants will depend on when they leave employment at the factor. If they stayed for the full duration of the trial, they will have undergone a maximum of 18 months (December 2023).
Eligibility Criteria
You may qualify if:
- Aged 30 years and above
- Distance visual acuity \>= 6/12 in both eyes
- Presence of presbyopia, defined as the inability, correctable with reading glasses, to read the N8 line using both eyes together, on a tumbling near vision chart at a distance of 25cm, 30cm, 40cm, and 50cm based on workers working distance
- Employed at the factory for \>=3months in the sewing department
You may not qualify if:
- Current ownership of reading or distance glasses (regardless of accuracy)
- Obvious evidence of ocular disease in either eye detected during the eye examination, or history of such disease based on self-report
- Low likelihood of completing follow-up in the study due to current plans to move out of the area or leave employment at Shahi during the follow-up period
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Queen's University, Belfastlead
- VisionSpringcollaborator
- Clearlycollaborator
- University of Michigancollaborator
- Good Business Labcollaborator
- Zhongshan Ophthalmic Center, Sun Yat-sen Universitycollaborator
Study Sites (1)
Good Business Lab
Bengaluru, Karantaka, 560102, India
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nathan G Congdon, MD, MPH
Queen's University, Belfast
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Study personnel assessing trial outcomes will be masked as to participants assignment, which will be simplified by the fact that there will be participants with and without glasses at both Intervention and Control. It is not ethical in this setting to provide Control participants with placebo treatment (glasses with zero power lenses), but participants will not be informed of either the overall design of the study or the explicit treatment intervention assignment.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
October 21, 2020
First Posted
December 4, 2020
Study Start
May 21, 2022
Primary Completion
March 30, 2023
Study Completion
June 5, 2025
Last Updated
April 29, 2024
Record last verified: 2024-04